SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-18-017147
Filing Date
2018-12-06
Accepted
2018-12-06 18:11:54
Documents
2
Period of Report
2018-11-26

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3472
2 ex-24.htm EX-24 9069
  Complete submission text file 0001493152-18-017147.txt   14013
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Issuer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
Assistant Director 9

Mailing Address C/O CANCER GENETICS INC. 201 ROUTE 17 NORTH, 2ND FLOOR RUTHERFORD NJ 07070
Business Address
Miles Michael Glenn (Reporting) CIK: 0001760938 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35817 | Film No.: 181221826